NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. Stock News
$0.600
-0.0598 (-9.06%)
At Close: Mar 27, 2024
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
08:17am, Saturday, 04'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
10:49am, Thursday, 02'nd Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that final participant dosing has been administered i
BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar
12:50pm, Wednesday, 01'st Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, will hold a Key Opinion Leader (KOL) webinar on the Company's Alzheim
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that addre
So far Monday, June 29, NASDAQ is up 3.38% and the S&P is up 2.09%. Let’s take a look at
Arizona Metals Corp. (TSX.V:AMC) (the “Company” or “Arizona Metals”) is pleased to announce that drilling at the South Zone of its Kay Mine Project, l
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
Maxim Group Gives a Buy Rating to Titan Pharmaceuticals (TTNP) - Markets
05:24pm, Thursday, 25'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Titan Pharmaceuticals (TTNP – Research Report) today and set a
Soligenix (SNGX) Receives a Buy from Maxim Group - Markets
05:16pm, Thursday, 25'th Jun 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Soligenix (SNGX – Research Report),
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
12:00am, Thursday, 25'th Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 24)
ACADIA...
BrainStorm to study stem cell treatment in Alzheimer's patients
01:06pm, Wednesday, 24'th Jun 2020
BrainStorm Cell Therapeutics Inc said on Wednesday it will begin a clinical trial of its experimental stem cell treatment in patients with Alzheimer's disease. The U.S.-Israeli company is already con
Reuters Health News Summary
01:00pm, Wednesday, 24'th Jun 2020
There were 2,531 new coronavirus infections reported in the past 24 hours, raising the total number of cases to 212,501, along with 9,996 deaths in all, the ministry said on Wednesday.
BrainStorm to study stem cell treatment in Alzheimer's patients
11:56am, Wednesday, 24'th Jun 2020
BrainStorm Cell Therapeutics Inc said on Wednesday it will begin a clinical trial of its experimental stem cell treatment in patients with Alzheimer's disease.
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
11:00am, Wednesday, 24'th Jun 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a new clinical program focused on the development of